Status:
ACTIVE_NOT_RECRUITING
Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
The Leona M. and Harry B. Helmsley Charitable Trust
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Brief Summary
Inflammatory bowel disease (IBD), consisting of two major forms, Crohn's disease (CD) and ulcerative colitis, affects more than 1.6 million people in the United States alone. Despite current therapies...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Provision of consent form
- Male or female greater than or equal to 18 years old
- Healthy volunteers without IBD undergoing colonoscopy for colorectal cancer screening or patients with a diagnosis of Crohn's disease (CD) confirmed by endoscopy or radiology assessment undergoing colonoscopy for clinical care
- Exclusion criteria:
- Pregnancy
- Coagulopathy or bleeding disorder
- Renal or hepatic impairment
- History of organ transplantation
Exclusion
Key Trial Info
Start Date :
December 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2027
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT04113733
Start Date
December 17 2019
End Date
February 1 2027
Last Update
November 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232